Report date: Apr 30, 2024
Conflict count: 350192
Publisher: Geneesmiddelenbulletin Foundation
Title count: 1
Conflict count: 3


==========================================================

Created: 2022-03-30 08:52:02.0
ConfID: 6459660
CauseID: 1525180708
OtherID: 1497282136
JT: Ge-Bu
MD: Cox, 35 40 ,4,1,2021, Erlotinib 
DOI: 10.35351/gebu.2021.4.8(Journal) (6459660-N )
DOI: 10.35351/gebu.nl.2021.4.8(Journal)
==========================================================

Created: 2022-03-31 09:12:35.0
ConfID: 6460676
CauseID: 1525305227
OtherID: 1514963137
JT: Ge-Bu
MD: Stolk, 117 119 ,11,1,2021, Living systematic reviews 
DOI: 10.35351/gebu.2021.11.21(Journal) (6460676-N )
DOI: 10.35351/gebu.nl.2021.11.21(Journal)
==========================================================

Created: 2022-08-29 07:28:00.0
ConfID: 6578543
CauseID: 1539942866
OtherID: 1539942866
JT: Ge-Bu
MD: Stolk, 37 39 ,5,1,2022, Antiviral drugs for COVID-19 
DOI: 10.35351/gebu.2022.5.19(Journal) (6578543-N )
DOI: 10.35351/gebu.2022.5.9(Journal)